Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308
Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308

Is Strut Health legit?

Strut Health checked against the public record: FDA warning letters, LegitScript certification, the pharmacy it dispenses through, and the states it is licensed to ship to.

By Sam Reed · Founder and data lead
The short answer
Strut Health is a real company, and the FDA has written to it about how it sells medication: one open warning letter, quoted and linked below. Read it before you decide.
The checks

What the public record shows

CheckWhat we foundSource
FDA warning letters1 openFDA warning letter list
LegitScript certificationCertification badge displayedProvider site
Dispensing pharmacyNot publishedProvider site
Pharmacy in the 503B registerNo match — the pharmacy it names is not a registered 503B, or names no pharmacyFDA outsourcing facility register
States it ships to49 statesProvider site
Medication typeCompounded only — not FDA-approved productsProvider site
The letters

What the FDA wrote to Strut Health

  • StrutFeb 20, 2026No closeout published

    What the website claimed

Context

What an FDA warning letter is

It is a letter. The FDA writes to a company to say which of its practices the agency believes break the law, and asks it to fix them. That is the whole mechanism: a written notice, published so anyone can read it.

It is the FDA’s position, not a court’s finding. The company can reply, and can disagree. The agency states in these letters that failing to address the problems may lead to further action such as seizure or an injunction — which tells you the letter itself is not yet either of those things.

A warning letter does not recall a product, suspend a licence or close a business. It does not mean that medicine already dispensed was unsafe. When the FDA is satisfied the problems are fixed, it publishes a closeout letter.

What it does tell you is that a regulator looked at this company and wanted something changed. The useful question is what — and the quoted passage above answers it more precisely than any summary can.

Related pages · 1 pages
Data sources · cited with retrieval dates

NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.